Works matching AU 徐江雁

Results: 16

中医 “痰” 与应激颗粒的相关性阐释.

Published in:

Journal of Traditional Chinese Medicine (1001-1668), 2025, v. 66, n. 4, p. 329, doi. 10.13288/j.11-2166/r.2025.04.001

By:

王涛;
张振强;
谢治深;
张效威;
徐江雁

Publication type:

Article

中药联合二甲双胍治疗糖尿病配伍规律研究.

Published in:

Science Technology & Engineering, 2023, v. 23, n. 26, p. 11145

By:

杜争;
吴宿慧;
李寒冰;
李根林;
徐江雁

Publication type:

Article

血竭化学成分及其糖尿病肾脏疾病肾小管损伤保护作用评价.

Published in:

China Journal of Chinese Materia Medica, 2024, v. 49, n. 5, p. 1249, doi. 10.19540/j.cnki.cjcmm.20231207.202

By:

周露;
段亚飞;
王奕航;
任尧;
张效威;
李汉伟;
张振强;
徐江雁;
王潘

Publication type:

Article

基于GLP-1R/cAMP/PKA/CREB 的泽泻汤促进白色脂肪棕色化/激活棕色脂肪作用机制研究.

Published in:

China Journal of Chinese Materia Medica, 2023, v. 48, n. 21, p. 5851, doi. 10.19540/j.cnki.cjcmm.20230710.704

By:

丁婧;
赵洁;
王萌萌;
苏烜;
高改;
徐江雁;
谢治深

Publication type:

Article

泽泻汤调控AKT/TFEB促进肝细胞脂噬机制研究.

Published in:

China Journal of Chinese Materia Medica, 2022, v. 47, n. 22, p. 6183, doi. 10.19540/j.cnki.cjcmm.20220706.702

By:

梦瑶;
李二稳;
高改;
付中学;
张效威;
王辉;
王潘;
张振强;
徐江雁;
谢治深

Publication type:

Article

基于LKB1/ AMPK/ PGC-1α 的泽泻汤改善非酒精性脂肪肝作用机制研究.

Published in:

China Journal of Chinese Materia Medica, 2022, v. 47, n. 2, p. 453, doi. 10.19540/j.cnki.cjcmm.20211008.402

By:

王梦瑶;
高改;
李二稳;
张效威;
王辉;
徐江雁;
张振强;
王潘;
谢治深

Publication type:

Article

白术中新桉叶烷倍半萜类成分及其 SREBPs 抑制活性.

Published in:

China Journal of Chinese Materia Medica, 2022, v. 47, n. 2, p. 428, doi. 10.19540/j.cnki.cjcmm.20211014.201

By:

许睿珠;
赵璇;
,杜月月;
许梦莎;
刘新光;
谢治深;
高松;
徐江雁;
王潘

Publication type:

Article

中医药调控细胞焦亡治疗糖尿病肾脏疾病的机制探讨.

Published in:

Chinese Archives of Traditional Chinese Medicine, 2025, v. 43, n. 1, p. 171, doi. 10.13193/j.issn.1673-7717.2025.01.030

By:

段亚飞;
石贤聪;
吕明真;
徐江雁;
张振强;
苗晋鑫;
谢治深;
张效威

Publication type:

Article

陈皮的化学成分和药理作用研究进展.

Published in:

Chinese Archives of Traditional Chinese Medicine, 2024, v. 42, n. 6, p. 41, doi. 10.13193/j.issn.1673-7717.2024.06.008

By:

关徐涛;
杨鹤年;
张津铖;
徐江雁

Publication type:

Article

糖尿病肾脏疾病预后影响因素的 COX 比例风险回归模型.

Published in:

Chinese Archives of Traditional Chinese Medicine, 2024, v. 42, n. 2, p. 28, doi. 10.13193/j.issn.1673-7717.2024.02.007

By:

陈占科;
陈凯丽;
应春苗;
冯素香;
崔伟锋;
徐江雁;
袁婷婷;
李耀洋

Publication type:

Article

基于 NLRP3 / CASP1 / GSDMD 通路探讨益肾通络方抑制糖尿病肾脏疾病小鼠足细胞焦亡的作用机制.

Published in:

Journal of Beijing University of Traditional Chinese Medicine, 2023, v. 46, n. 11, p. 1529, doi. 10.3969/j.issn.1006-2157.2023.11.008

By:

赵靓;
向世勰;
谢治深;
王潘;
石贤聪;
王佳俊;
段亚飞;
张振强;
陈洁;
徐江雁;
张效威

Publication type:

Article

Zeste 基因抑制子基因 12 在糖尿病肾脏病模型大鼠肾组织中的表达.

Published in:

Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu, 2023, v. 27, n. 8, p. 1179, doi. 10.12307/2022.1001

By:

赵璐;
赵逸菲;
高达;
刘艳芳;
付婷婷;
徐江雁

Publication type:

Article

芹菜素通过抑制NF-κB信号通路缓解高糖对雪旺细胞的损伤.

Published in:

Journal of Xi'an Jiaotong University (Medical Sciences), 2019, v. 40, n. 6, p. 1007, doi. 10.7652/jdyxb201906032

By:

赵璐;
孙俊波;
许华;
付婷婷;
徐江雁

Publication type:

Article

泽泻汤基于PI3K/AKT 通路调节巨噬细胞M1/M2 极化平衡机制研究.

Published in:

Chinese Journal of Immunology, 2024, v. 40, n. 8, p. 1684, doi. 10.3969/j.issn.1000-484X.2024.08.019

By:

李二稳;
崔正浩;
高改;
付中学;
张效威;
王辉;
张振强;
徐江雁;
谢治深

Publication type:

Article

网络药理学联合分子对接及细胞实验探讨白术治疗非酒精性脂肪肝的作用机制.

Published in:

Traditional Chinese Drug Research & Clinical Pharmacology, 2025, v. 36, n. 5, p. 760, doi. 10.19378/j.issn.1003-9783.2025.05.011

By:

刘长鑫;
徐江雁;
张振强;
张效威;
高改;
王涛;
谢治深

Publication type:

Article

益肾通络方及活性成分地黄苷 D 抑制肾小管上皮-间质转化的机制研究.

Published in:

Traditional Chinese Drug Research & Clinical Pharmacology, 2025, v. 36, n. 1, p. 30, doi. 10.19378/j.issn.1003-9783.2025.01.005

By:

刘瑞頔;
张振强;
张效威;
吴延烧;
徐江雁;
谢治深

Publication type:

Article